Abstract
Background
Crouzon syndrome with acanthosis nigricans also named Crouzono-dermo-skeletal is a clinically and genetically distinct entity. It associates a craniofacial phenotype to anomalies of the skin and long bones. This syndrome is due to a specific mutation in FGFR3 gene that can be identified by genetic testing.
Illustrative cases
As in our two patients, not all these features might be present and some will be patent only in the infancy or early childhood. Moreover, other organs such as the kidneys might be affected.
Discussion
Because several organs might be affected the recognition of such syndrome is important for a correct management of the patient as well as a proper information and genetic counseling of the families.
Similar content being viewed by others
References
Arnaud-López L, Fragoso R, Mantilla-Capacho J, Barros-Núñez P (2007) Crouzon with acanthosis nigricans. Further delineation of the syndrome. Clin Genet 72:405–410
Berk DR, Spector EB, Bayliss SJ (2007) Familial acanthosis nigricans due to K650T FGFR3 mutation. Arch Dermatol 143:1153–1156
Breitbart AS, Eaton C, McCarthy JG (1989) Crouzon’s syndrome associated with acanthosis nigricans: ramifications for the craniofacial surgeon. Ann Plast Surg 22(4):310–315
Cohen MM Jr (1999) Let’s call it “Crouzonodermoskeletal syndrome” so we won’t be prisoners of our own conventional terminology. Am J Med Genet 84(1):74
Cohen MM Jr (2009) Cloverleaf skulls: etiologic heterogeneity and pathogenetic variability. J Craniofac Surg 20(Suppl 1):652–656
Curth HO (1968) The necessity of distinguishing four types of acanthosis nigricans. In: Jadassohn W, Schirren CG (eds) Congressus internationalis dermatologiae Munich vol1. Springer, Berlin, pp 557–558
Everett ET, Hartsfield KG Jr, Murdoch-Kinch CA (1996) FGFR3 mutation in Crouzon syndrome with acanthosis nigricans and abnormal MCPP analysis. Am J Hum Genet 59:257
Friedhofer H, Ocharan AM, Sturtz GP, Fonseca AS, Coltro PS, Ferreira MC (2006) Surgical treatment for eyelid deformity in Crouzon syndrome associated with acanthosis nigricans: case report. Clinics (Sao Paulo) 61(2):171–174
Gines E, Rodriguez-Pichardo A, Jorquera E, Moreno JC, Camacho F (1996) Crouzon disease with acanthosis nigricans and melanocytic nevi. Pediatr Dermatol 13:18–22
Goriely A, Lord H, Lim J, Johnson D, Lester T, Firth HV, Wilkie AOM (2010) Germline and somatic mosaicism for FGFR2 mutation in a mother of a child with Crouzon syndrome: implications for genetic testing in ‘paternal age-effect’ syndromes. Am J Med Genet A 152A:2067–2073
Gupta AK, Koley S, Choudhary S, Bhake A, Saoji V, Salodkar A (2010) A rare association of acanthosis nigricans with Crouzon syndrome. Indian J Dermatol Venereol Leprol 76(1):65–67
Horton WA, Degnin CR (2009) FGFs in endochondral skeletal development. Trends Endocrinol Metab 20(7):341–348
Jeftha A, Stephen L, Morkel JA, Beighton P (2004) Crouzonodermoskeletal syndrome. J Clin Pediatr Dent 28(2):173–176
Koizumi H, Tomoyori T, Sato KC, Ohkawara A (1992) An association of acanthosis nigricans and Crouzon syndrome. J Dermatol 19(2):122–126
Lajeunie E, El Ghouzzi V, Le Merrer M, Munnich A, Bonaventure J, Renier D (1999) Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation. J Med Genet 36(1):9–13
Lapunzina P, Fernández MC, Varela Junquera JM, Arberas C, Tello AM, Gracia Bouthelier R (2002) Crouzon’s syndrome with acanthosis nigricans. An Esp Pediatr 56(4):342–346
Martinez-Perez D, Vander Woude DL, Barnes PD, Scott RM, Mulliken JB (1996) Jugular foraminal stenosis in Crouzon syndrome. Pediatr Neurosurg 25(5):252–255
Meyers GA, Orlow SJ, Munro IR, Pzylepa KA, Jabs EW (1995) Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 11:462–464
Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, Markowitz RI, Robin NH, Nwokoro N, Mulvihill JJ, Losken HW, Mulliken JB, Guttmacher AE, Wilroy RS, Clarke LA, Hollway G, Adès LC, Haan EA, Mulley JC, Cohen MM Jr, Bellus GA, Francomano CA, Moloney DM, Wall SA, Wilkie AO et al (1997) A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 60(3):555–564
Nagase T, Nagase M, Hirose S, Ohmori K (2000) Crouzon syndrome with acanthosis nigricans: case report and mutational analysis. Cleft Palate Craniofac J 37(1):78–82
Pannier S, Couloigner V, Messaddeq N, Elmaleh-Bergès M, Munnich A, Romand R, Legeai-Mallet L (2009) Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia. Biochim Biophys Acta 1792(2):140–147
Reddy BS, Garg BR, Padiyar NV, Krishnaram AS (1985) An unusual association of acanthosis nigricans and Crouzon’s disease—a case report. J Dermatol 12(1):85–90
Renier D, El-Ghouzzi V, Bonaventure J, Le Merrer M, Lajeunie E (2000) Fibroblast growth factor receptor 3 mutation in nonsyndromic coronal synostosis: clinical spectrum, prevalence, and surgical outcome. J Neurosurg 92(4):631–636
Robson CD, Mulliken JB, Robertson RL, Proctor MR, Steinberger D, Barnes PD, McFarren A, Müller U, Zurakowski D (2000) Prominent basal emissary foramina in syndromic craniosynostosis: correlation with phenotypic and molecular diagnoses. AJNR Am J Neuroradiol 21(9):1707–1717
Schweitzer DN, Graham JM Jr, Lachman RS, Jabs EW, Okajima K, Przylepa KA, Shanske A, Chen K, Neidich JA, Wilcox WR (2001) Subtle radiologic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3. Am J Med Genet 98:75–91
Sharda S, Panigrahi I, Gupta K, Singhi S, Kumar R (2010) A newborn with acanthosis nigricans: can it be Crouzon syndrome with acanthosis nigricans? Pediatr Dermatol 27(1):43–47
Sinha S, Schwartz RA (2007) Juvenile acanthosis nigricans. J Am Acad Dermatol 57:502–508
Superti-Furga A, Locher M, Eich G, Huisman T, Steinlin M, King L, Cohn DH, Steinmann B, Sailer HF, Bolthauser E (1996) A boy with craniosynostosis, choanal atresia, acantjosis nigricans, hydrocephalus and hydromyelia, stenosis of foramen magnum and vertebral canal, and multiple desmo-osteoblastomas of the jaws: pleiotropic effects of FGFR3 A391G mutation causing a distinct craniofacial-skeletal-ectodermal dysplasia. Am J Hum Genet 59:A287
Torley D, Bellus GA, Munro CS (2002) Genes growth factors and acanthosis nigricans. Br J Dermatol 147:1096–1101
Wilkes D, Rutland P, Pulleyn LJ, Reardon W, Moss C, Ellis JP, Winter RM, Malcolm S (1996) A recurrent mutation ala391glu in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans. J Med Genet 33:744–748
Witkowski JA, Parish LC (1976) A new face for Crouzon’s syndrome. Int J Dermatol 15:444–445
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Di Rocco, F., Collet, C., Legeai-Mallet, L. et al. Crouzon syndrome with acanthosis nigricans: a case-based update. Childs Nerv Syst 27, 349–354 (2011). https://doi.org/10.1007/s00381-010-1347-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-010-1347-z